Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share
-
Shares outstanding
-
40,291,821
-
Total 13F shares
-
9,847,143
-
Share change
-
-361,633
-
Total reported value
-
$19,972,820
-
Price per share
-
$2.06
-
Number of holders
-
15
-
Value change
-
-$752,585
-
Number of buys
-
5
-
Number of sells
-
3
Institutional Holders of Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) as of Q2 2023
As of 30 Jun 2023,
Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,847,143 shares.
The largest 10 holders included
M&G INVESTMENT MANAGEMENT LTD, Alphabet Inc., SC CHINA HOLDING Ltd, DC Funds, LP, BlueCrest Capital Management Ltd, Baird Financial Group, Inc., Liontrust Investment Partners LLP, Johns Hopkins University, RENAISSANCE TECHNOLOGIES LLC, and Ipswich Investment Management Co., Inc..
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.